Clinical Trial Update: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating docetaxel with or without infliximab for cancer-related weight loss in unresectable non-small cell lung cancer; infliximab treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Remicade (infliximab)
• Taxotere (docetaxel)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anorexia, Cachexia | Phase 3 | Status: COMPLETED